New York, USA – 31st July – In a landmark moment for SurgEase Innovations Ltd, the first-ever LumenEye® procedure in the United States has been successfully performed at the Mount Sinai Health System in New York City. The procedure was carried out by Dr. Patricia Sylla, MD, FACS, FASCRS, a renowned colorectal surgeon and key opinion leader in the field.
This milestone represents not only a personal achievement for Fareed Iqbal, CEO of SurgEase Innovations, but also a significant leap forward in expanding access to advanced diagnostic tools for colorectal care across the United States.
“Words cannot express how proud we are to finally unlock the value of the LumenEye for U.S. patients,” said Fareed Iqbal. “This is a pivotal moment for our company and for the future of minimally invasive colorectal diagnostics.”
The LumenEye® platform, developed by SurgEase Innovations, is designed to enhance diagnostic speed and accuracy in lower GI examinations. Already gaining traction in the UK and Europe, its entry into the U.S. healthcare system marks a transformative step in global expansion.
Fareed Iqbal will be traveling across the U.S. in the coming months to support the deployment of the LumenEye system in additional clinical centers.
This achievement has been recognized by key professional bodies, including the European Society of Coloproctology (ESCP), the Association of Coloproctology of Great Britain and Ireland (ACPGBI), and the American Society of Colon and Rectal Surgeons (ASCRS).
Stay tuned for further updates as SurgEase Innovations continues its mission to bring cutting-edge, accessible technology to colorectal patients worldwide.
